pembrolizumab (Q13896859)

From Wikidata
Jump to navigation Jump to search
pharmaceutical drug
  • MK-3475
  • lambrolizumab
  • Keytruda
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    pembrolizumab
    pharmaceutical drug
    • MK-3475
    • lambrolizumab
    • Keytruda

    Statements

    mass
    149,000 dalton
    1 reference
    stated in
    DrugBank
    DrugBank ID
    DB09037

    Identifiers

    HSDB ID
    8257
    1 reference
    stated in
    Hazardous Substances Data Bank
    HSDB ID
    8257
    publication date
    28 October 2019
    title
    PEMBROLIZUMAB (English)
    retrieved
    10 May 2021
    LiverTox ID
    Pembrolizumab
    0 references
    EC number
    807-012-2
    1 reference
    stated in
    ECHA Substance Infocard database
    ECHA Substance Infocard ID
    100.234.370
    retrieved
    27 December 2018
    title
    [Name confidential or not available] (English)
    quotation
    CAS no.: 1374853-91-4 (English)
    ECHA Substance Infocard ID
    100.234.370
    1 reference
    stated in
    ECHA Substance Infocard database
    ECHA Substance Infocard ID
    100.234.370
    retrieved
    27 December 2018
    title
    [Name confidential or not available] (English)
    quotation
    CAS no.: 1374853-91-4 (English)
    DrugBank ID
    DB09037
    0 references
    UNII
    DPT0O3T46P
    1 reference
    stated in
    NDF-RT
    NDF-RT ID
    N0000191088
    language of work or name
    English
    title
    PEMBROLIZUMAB (English)
    retrieved
    19 January 2016
    Freebase ID
    /m/0tkhdkd
    0 references
    UMLS CUI
    C3658706
    0 references
     
    edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q13896859&oldid=2302822308"